UMass Chan Medical School · 1 week ago
Post Doc - Wolfe Lab
Worcester, MA
Full-time
Onsite
Senior LevelUMass Chan Medical School is seeking a Postdoctoral researcher for the Wolfe Laboratory to develop therapeutic genome editing reagents for muscular dystrophy and cancer. The role focuses on creating and translating genome editing technologies for clinical applications, while also providing opportunities to engage in cutting-edge research and present findings at national meetings.
EducationHigher EducationMedical
Responsibilities
The development of prime editing reagents with high activity and specificity for the precise correction of common pathogenic mutations associated with Limb Girdle Muscular Dystrophy
The development of genome editing reagents for selective killing of cancer cells harboring gene amplifications
The utilization of unbiased genome-wide techniques for assessing off-target events and other genomic alterations potentially associated with genome editing
The translation of the developed genome editing reagents to clinical application through in vivo safety and efficacy studies in relevant mouse models
Qualification
Required
Ph.D. in biology, biochemistry, chemistry or a related biomedical science
Strong oral and written communication skills
Eager to present research results at national meetings
Preferred
Prior experience with genome editing systems
Prior experience with cell culture
Prior experience with deep-sequencing technologies
Prior experience with mouse disease models
Company
UMass Chan Medical School
Massachusetts’ first and only public academic health sciences center is made up of three graduate schools.
Founded in 1962
5001-10000 employees
H1B Sponsorship
UMass Chan Medical School has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (2)
2022 (1)
2021 (1)
Funding
Current Stage
Late StageTotal Funding
$13.6MKey Investors
Centers for Disease Control and PreventionCommonwealth of Massachusetts
2025-11-18Grant· $2M
2024-04-03Grant· $11.6M
Leadership Team
M
Marc Uknis
Adjunct Associate Professor Of Surgery, Microbiology & Applied Physiology
Michael Collins
Chancellor
Recent News
2026-01-18
2026-01-03
Company data provided by crunchbase